Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan-Yi Meng

Showing results (81-90 of 118) with videos related to

Pageof 12
Sort By:
AI Zheng = Aizheng = Chinese Journal of Cancer|December 25, 2003
[Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia]Fan-Yi Meng, Long-Jiang Yang, Bing Xu, et al.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA|December 18, 2003
[Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome]Fan-yi Meng, Jin Sun, Qi-fa Liu, et al.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA|November 30, 2004
[Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia]Qi-fa Liu, Zhi-ping Fan, Jing Sun, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 17, 2012
[Reversal effect of LBH589 alone or in combination with bortezomib on drug-resistance in myeloid leukemia and its mechanism]Xue-Jie Jiang, Fan-Yi Meng, Hong-Sheng Zhou, et al.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA|October 16, 2003
[Modified FLAG regimen in the management of refractory acute myeloid leukemia]Long-jiang Yang, Fan-yi Meng, Bing Xu, et al.
Biomedical Reports|October 2, 2018
Influence of initiation time and white blood cell count on the efficacy of cytotoxic agents in acute promyelocytic leukemia during induction treatmentFang Xu, Chang-Xin Yin, Chun-Li Wang, et al.
Disease Markers|July 22, 2014
Immunophenotypes and immune markers associated with acute promyelocytic leukemia prognosisFang Xu, Chang-Xin Yin, Chun-Li Wang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 17, 2004
[Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia]Xiao-Li Liu, Shu-Yun Zhou, Qing-Feng Du, et al.
Zhonghua Yi Xue Za Zhi|December 3, 2003
[Autologous transplantation of recombinant interleukine-2 activated bone marrow for acute promyelocytic leukemia]Qi-fa Liu, Jing Sun, Yu Zhang, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|September 4, 2009
[CD56 and CD11b antigen expressions in patients with acute monocytic leukemia and the clinical implications]Na Xu, Xiao-li Liu, Qing-feng DU, et al.
Pageof 12

Showing results (81-90 of 118) with videos related to

Sort By:
Pageof 12
AI Zheng = Aizheng = Chinese Journal of Cancer|December 25, 2003
[Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia]Fan-Yi Meng, Long-Jiang Yang, Bing Xu, et al.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA|December 18, 2003
[Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome]Fan-yi Meng, Jin Sun, Qi-fa Liu, et al.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA|November 30, 2004
[Therapeutic efficacy of hematopoietic stem cell transplantation in patients with chronic myelogenous leukemia]Qi-fa Liu, Zhi-ping Fan, Jing Sun, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 17, 2012
[Reversal effect of LBH589 alone or in combination with bortezomib on drug-resistance in myeloid leukemia and its mechanism]Xue-Jie Jiang, Fan-Yi Meng, Hong-Sheng Zhou, et al.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA|October 16, 2003
[Modified FLAG regimen in the management of refractory acute myeloid leukemia]Long-jiang Yang, Fan-yi Meng, Bing Xu, et al.
Biomedical Reports|October 2, 2018
Influence of initiation time and white blood cell count on the efficacy of cytotoxic agents in acute promyelocytic leukemia during induction treatmentFang Xu, Chang-Xin Yin, Chun-Li Wang, et al.
Disease Markers|July 22, 2014
Immunophenotypes and immune markers associated with acute promyelocytic leukemia prognosisFang Xu, Chang-Xin Yin, Chun-Li Wang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|April 17, 2004
[Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia]Xiao-Li Liu, Shu-Yun Zhou, Qing-Feng Du, et al.
Zhonghua Yi Xue Za Zhi|December 3, 2003
[Autologous transplantation of recombinant interleukine-2 activated bone marrow for acute promyelocytic leukemia]Qi-fa Liu, Jing Sun, Yu Zhang, et al.
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|September 4, 2009
[CD56 and CD11b antigen expressions in patients with acute monocytic leukemia and the clinical implications]Na Xu, Xiao-li Liu, Qing-feng DU, et al.
Pageof 12